Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
30/04/2026 02:51
April 30 (Reuters) - Microba Life Sciences Ltd MAP.AX: Q3 FY26 TOTAL REVENUE OF A$3.36M Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million